In accordance with the Jungraithmayr study, we observed that exhaled IL-8 reflects cancer biology as its concentrations increased in lung cancer patients compared to controls, particularly when progressing to the next stage of cancer. This evidence concerns the gene CXCL8 and lung cancer.